What Is BioRestorative Therapies, Inc. (BRTX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, BioRestorative Therapies, Inc.'s intrinsic value is estimated at a composite fair value of $0.35. Trading at $0.33, the stock is approaching fair value or slight overvaluation (implied return of +7.3%), as 7 of 11 models suggest limited further upside. Model dispersion is worth noting: EROIC targets $1.12 (+239.2%), versus ML-RIV at $0.01 (-97.6%). This +336.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About BRTX?
11 of 13 models are currently active for BRTX. Of these, 4 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates BRTX's intrinsic value at $0.21, implying -35.3% downside from the current price. See which stocks rank higher →
How Does BRTX Rank in Services-Misc Health & Allied Services, NEC?
Among 11 Services-Misc Health & Allied Services, NEC stocks, BRTX ranks #6 by Quality of Company score. CirclFi's QOC score of 6.6/10 evaluates 32 fundamental signals. A score of 6.6 indicates above-average quality.
BioRestorative Therapies, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BRTX a Value Trap?
CirclFi's Value Trap algorithm assigns BRTX a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for BioRestorative Therapies, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, BioRestorative Therapies, Inc. earns a quality score of 6.6/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +336.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BRTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BRTX's 11 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad